1. Home
  2. ARMP vs UXIN Comparison

ARMP vs UXIN Comparison

Compare ARMP & UXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

SELL

Current Price

$3.02

Market Cap

199.7M

Sector

Health Care

ML Signal

SELL

Logo Uxin Limited ADS

UXIN

Uxin Limited ADS

SELL

Current Price

$0.68

Market Cap

226.6M

ML Signal

SELL

Company Overview

Basic Information
Metric
ARMP
UXIN
Founded
N/A
2011
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
226.6M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
ARMP
UXIN
Price
$3.02
$0.68
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $17.50
N/A
AVG Volume (30 Days)
75.7K
★ 98.7K
Earning Date
11-12-2026
12-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$59.68
Revenue Next Year
N/A
$71.25
P/E Ratio
★ N/A
$4.05
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$0.71
52 Week High
$14.98
$4.18

Technical Indicators

Market Signals
Indicator
ARMP
UXIN
Relative Strength Index (RSI) 46.59 33.80
Support Level $2.77 N/A
Resistance Level $3.96 $1.02
Average True Range (ATR) 0.44 0.08
MACD -0.02 -0.00
Stochastic Oscillator 43.35 4.57

Price Performance

Historical Comparison
ARMP
UXIN

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates a car retailer, pioneering industry transformation with production, new retail experiences, and digital empowerment in China. With its inventory-owning model, it provides customers a comprehensive transaction solution that encompasses the entire value chain, ranging from used-car acquisition, inspection, and reconditioning, warehousing, as well as pre-sales and after-sales services. The group offers high-quality and value-for-money used cars as well as superior full suites of services to customers through a reliable, one-stop, and hassle-free transaction experience. It derives revenues from retail vehicle sales, wholesale vehicle sales, and other businesses. The Group generates its revenues in China.

Share on Social Networks: